comparemela.com

Latest Breaking News On - Fibrogen shareholder class action lawsuit - Page 1 : comparemela.com

FGEN INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fibrogen Inc

FGEN SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fibrogen Inc

Home / Top News / FGEN SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fibrogen Inc. FGEN SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fibrogen Inc. NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Fibrogen, Inc., (“Fibrogen” or the “Company”) (NASDAQ: FGEN) from November 8, 2019, through April 6, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.

FGEN INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Fibrogen Inc

FGEN INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Fibrogen Inc. April 14, 2021 20:32 ET | Source: Bernstein Liebhard LLP Bernstein Liebhard LLP New York, New York, UNITED STATES NEW YORK, April 14, 2021 (GLOBE NEWSWIRE) Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Fibrogen, Inc., ( Fibrogen or the Company ) (NASDAQ: FGEN) from November 8, 2019, through April 6, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.

FGEN INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fibrogen Inc

Share this article Share this article NEW YORK, April 15, 2021 /PRNewswire/ Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Fibrogen, Inc., ( Fibrogen or the Company ) (NASDAQ: FGEN) from November 8, 2019, through April 6, 2021 (the Class Period ). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934. If you  purchased Fibrogen securities, and/or would like to discuss your legal rights and options please visit Fibrogen Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.